Rabbit MTX1 (E4O1L) Monoclonal Antibody

Rabbit MTX1 (E4O1L) Monoclonal Antibody

Cat. No.: DAB-0012321

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Isotype IgG
Host Species Rabbit
Reactivity Human
Applications WB, IP, IF
Product Description Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human MTX1 protein.
Format Liquid
Purity Affinity purity
Target Information
Target Name MTX1
UniProt No. Q13505
Gene ID 4580
Gene Description Metaxin-1 and Metaxin-2 are part of the sorting and assembly machinery that have been associated with import of β-barrel proteins through the mitochondrial outer membrane. MTX1 and MTX2 can also function in mitochondrial trafficking in neurons. Studies of cells with a loss of MTX1 have shown that MTX1 is required for some forms of cell death, including TNF-α-induced cell death. Subsequent studies found that MTX1 and MTX2 can regulate TNF-α mediated apoptosis through association with the apoptotic effector protein Bak, and that phosphorylation of MTX1 controls Bak activation. MTX1 has also been shown to be targeted for basal piecemeal mitophagy in an LC3C- and p62/SQSMT1-dependent manner. MTX1 was identified as a regulator of sorafenib resistance in hepatocellular carcinoma by augmenting autophagy.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at –20 °C. Do not aliquot the antibody.
Storage Buffer Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top